心房颤动合并脑卒中的抗凝策略及综合管理建议  

Anticoagulation strategy and comprehensive management of patients with atrial fibrillation and stroke

作　　者：《中国心血管病研究》杂志编辑委员会 郭军 郑黎晖 姚焰 屈正 梅举[5] 王水云 Editorial Committee of Chinese Journal of Cardiovascular Research;YAO Yan;QU Zheng;MEI Ju;GUO Jun;ZHENG Li-hui

机构地区：[1]不详 [2]暨南大学附属第一医院 [3]中国医学科学院阜外医院 [4]《中国心血管病研究》杂志 [5]上海交通大学医学院附属新华医院

出　　处：《中国心血管病研究》2024年第6期481-509,共29页Chinese Journal of Cardiovascular Research

摘　　要：心房颤动合并脑卒中患者是再发脑卒中和出血的高危人群,其抗凝方案的制定是临床诊疗中的难点。本文根据国内外最新临床研究,参考相关指南,结合我国国情及临床实践,对抗凝适应证及方案进行了系统阐述,并根据现有证据做出推荐,以期促进和规范心房颤动合并脑卒中患者的抗凝策略和综合管理,指导临床应用。Patients with atrial fibrillation and stroke are at an increased risk of recurrent stroke and bleeding events.It is very challenging to make an anticoagulation strategy of this patients in clinical.Based on the latest trials and guidelines,and in the Chinese context and clinical practice,the present consensus comprehensively elaborates the anticoagulant strategy and makes recommendations based on the available evidence aiming to standardize and improve the anticoagulation treatment and comprehensive management of patients with atrial fibrillation and stroke.

关 键 词：心房颤动 脑卒中 抗凝治疗 CHA2DS2-VASc评分 HAS-BLED评分 NIHSS评分 口服抗凝药 华法林 

分 类 号：R541.7[医药卫生—心血管疾病]